GSTRX
Price
$9.69
Change
+$0.08 (+0.83%)
Updated
Jun 6 closing price
Net Assets
193.36M
VIGRX
Price
$217.30
Change
+$2.25 (+1.05%)
Updated
Jun 6 closing price
Net Assets
293.94B
Interact to see
Advertisement

GSTRX vs VIGRX

Header iconGSTRX vs VIGRX Comparison
Open Charts GSTRX vs VIGRXBanner chart's image
Goldman Sachs Strategic Growth R
Price$9.69
Change+$0.08 (+0.83%)
VolumeN/A
Net Assets193.36M
Vanguard Growth Index Investor
Price$217.30
Change+$2.25 (+1.05%)
VolumeN/A
Net Assets293.94B
GSTRX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSTRX vs. VIGRX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSTRX is a Buy and VIGRX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 294B vs. GSTRX (193M). VIGRX pays higher dividends than GSTRX: VIGRX (0.35) vs GSTRX (0.00). GSTRX was incepted earlier than VIGRX: GSTRX (16 years) vs VIGRX (33 years). GSTRX (1.57) is less costly to investors than VIGRX (0.17). GSTRX is a more actively managed with annual turnover of: 39.00 vs. VIGRX (11.00). GSTRX has a lower initial minimum investment than VIGRX: GSTRX (0) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 15.58 vs. GSTRX (8.34). VIGRX return over 5 years is better than : 109.00 vs. GSTRX (8.22).
GSTRXVIGRXGSTRX / VIGRX
Total Expense Ratio1.280.17753%
Annual Report Gross Expense Ratio1.570.17924%
Fund Existence16 years33 years-
Gain YTD1.3711.78077%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets193M294B0%
Annual Yield % from dividends0.000.35-
Returns for 1 year8.3415.5854%
Returns for 3 years26.7869.5838%
Returns for 5 years8.22109.008%
Returns for 10 years-20.82288.95-7%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYEL12.761.30
+11.34%
Lyell Immunopharma Inc
SYF59.221.77
+3.08%
Synchrony Financial
AI25.950.61
+2.41%
C3ai
SLP27.55-0.24
-0.86%
Simulations Plus
CSCI3.61-0.11
-2.95%
COSCIENS Biopharma Inc